Paresthesia: Clinical Trials

6 trials for Paresthesia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 31Completed 1

Follow Paresthesia: new trials by email Literature Review of Paresthesia trials Research Report on Paresthesia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children
Midazolam, Lidocaine-Midazolam, Placebo - Burning Nose
Phase 2 / Phase 3CompletedLatakia University632017-06-012018-11-05
ST266 in UV-induced Inflammation
ST266 immediate, ST266 delayed - Skin Burns
Phase 2CompletedNoveome Biotherapeutics, formerly Stemnion102015-03-012019-05-15
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
incobotulinumtoxinA, Placebo - Restless Leg Syndrome
Phase 2CompletedYale University242012-09-012016-03-21
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Low Dose: 16 mg Engensis (VM202), High Dose: 32 mg Engensis (VM202), Control- Placebo (normal saline) - Painful Diabetic Neuropathies
Phase 2CompletedHelixmith Co., Ltd.1042012-08-012025-10-06
Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection
PP4001, Placebo - Urinary Tract Infection
Phase 2CompletedPinnacle Pharmaceuticals, Inc.2612011-07-012011-10-19
Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy
Fluoride varnish, Oral Hygiene, CPP-ACP - Mucositis, Dry Mouth
Phase 2CompletedAzad University of Medical Sciences302011-03-012012-11-29

Narrower conditions

Diabetic Neuropathies (1)  ·  Dysuria (1)  ·  Hypesthesia (1)  ·  Infections (1)  ·  Mucositis (1)  ·  Neuralgia (1)  ·  Pain (1)  ·  Restless Legs Syndrome (1)  ·  Urinary Tract Infections (1)  ·  Xerostomia (1)

Broader conditions

Nervous System Diseases (6)  ·  Neurologic Manifestations (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Sensation Disorders (6)  ·  Signs and Symptoms (6)  ·  Somatosensory Disorders (6)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)  ·  Dyssomnias (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)

Interventions

Genetic Therapy (1)  ·  Midazolam (1)  ·  Oral Hygiene (1)  ·  Saline Solution (1)  ·  Toothbrushing (1)  ·  casein phosphopeptide-amorphous calcium phosphate nanocomplex (1)  ·  incobotulinumtoxinA (1)

Sponsors

Azad University of Medical Sciences (1)  ·  Helixmith Co., Ltd. (1)  ·  Latakia University (1)  ·  Noveome Biotherapeutics, formerly Stemnion (1)  ·  Pinnacle Pharmaceuticals, Inc. (1)  ·  Yale University (1)

Countries

United States (3)  ·  Iran (1)  ·  South Korea (1)  ·  Syria (1)

Top investigators

Bahman Jabbari, MD (1)  ·  David L Steed, MD (1)  ·  Elma D Baron, MD (1)  ·  Jack Kessler, MD (1)  ·  Nabih Raslan, Dr. (1)  ·  Sepideh Banava, Assist-Prof (1)  ·  Suma Krishnan (1)  ·  Walaa Khalil, Dr. (1)

Results publications

PMID 26000320, PMID 27739142, PMID 30274305